294 related articles for article (PubMed ID: 23093371)
21. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
22. Concurrent Hypermethylation of
Wang H; Duan XL; Qi XL; Meng L; Xu YS; Wu T; Dai PG
Mol Cells; 2017 Jan; 40(1):45-53. PubMed ID: 28152305
[TBL] [Abstract][Full Text] [Related]
23. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
[TBL] [Abstract][Full Text] [Related]
24. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
[TBL] [Abstract][Full Text] [Related]
25. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
Yang Y; Zhang Q; Xu F; Chang C; Li X
Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
[TBL] [Abstract][Full Text] [Related]
26. [Promoter methylation status of SFRP genes and induced apoptosis by demethylation in Jurkat cells].
Xu C; Shen J; Liao B; Fu H; Zhou H; Qi Y; Huangfu Z; Chen Y; Chen J
Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):51-5. PubMed ID: 26876254
[TBL] [Abstract][Full Text] [Related]
27. Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders.
García-Ibarbia C; Delgado-Calle J; Casafont I; Velasco J; Arozamena J; Pérez-Núñez MI; Alonso MA; Berciano MT; Ortiz F; Pérez-Castrillón JL; Fernández AF; Fraga MF; Zarrabeitia MT; Riancho JA
Gene; 2013 Dec; 532(2):165-72. PubMed ID: 24096177
[TBL] [Abstract][Full Text] [Related]
28. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
29. Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.
Schmelz K; Sattler N; Wagner M; Lübbert M; Dörken B; Tamm I
Leukemia; 2005 Jan; 19(1):103-11. PubMed ID: 15510208
[TBL] [Abstract][Full Text] [Related]
30. Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance.
Mukherjee N; Bhattacharya N; Alam N; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2012 Feb; 103(2):210-20. PubMed ID: 22026417
[TBL] [Abstract][Full Text] [Related]
31. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
32. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.
Liu TH; Raval A; Chen SS; Matkovic JJ; Byrd JC; Plass C
Cancer Res; 2006 Jan; 66(2):653-8. PubMed ID: 16423993
[TBL] [Abstract][Full Text] [Related]
33. Methylation of secreted frizzled related protein gene in acute leukemia patients in China.
Shen JZ; Xu CB; Fu HY; Wu DS; Zhou HR; Fan LP
Asian Pac J Cancer Prev; 2011; 12(10):2617-21. PubMed ID: 22320963
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
[TBL] [Abstract][Full Text] [Related]
35. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of SFRP5 promotes the metastasis and invasion of chondrosarcoma by expression inhibition and Wnt signaling pathway activation.
Sheng W; Zhang ZC; Shi DY; Wang BC; Wu Q; Shao ZW; Yang SH; He TC; Liu JX
Chem Biol Interact; 2018 Dec; 296():1-8. PubMed ID: 30125549
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.
Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E
Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147
[TBL] [Abstract][Full Text] [Related]
38. Secreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemia.
Cheng CK; Li L; Cheng SH; Ng K; Chan NP; Ip RK; Wong RS; Shing MM; Li CK; Ng MH
Blood; 2011 Dec; 118(25):6638-48. PubMed ID: 22031861
[TBL] [Abstract][Full Text] [Related]
39. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
40. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers.
Takada T; Yagi Y; Maekita T; Imura M; Nakagawa S; Tsao SW; Miyamoto K; Yoshino O; Yasugi T; Taketani Y; Ushijima T
Cancer Sci; 2004 Sep; 95(9):741-4. PubMed ID: 15471560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
